TrialCancer2022

A randomized phase 2 trial of nivolumab, gemcitabine, and cisplatin or nivolumab and ipilimumab in previously untreated advanced biliary cancer: BilT-01.

Vaibhav Sahai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.